Delivery Order SPE2DB25D3012-SPE2DB26FWVSP
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count packages) with a contract value of $5,375.11. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The work is scheduled for completion by November 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Veltassa 8.4 GM Powder Packet in a quantity of 30 units, with a ceiling value of $2,716.20. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive, non-set-aside award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $7,533.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count units). This is a firm fixed-price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Veltassa is a potassium-binding medication used to treat hyperkalemia, a condition characterized by elevated potassium levels in the blood....
- The Defense Logistics Agency awarded a $13,686.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count units). This is a non-set-aside competitive award with an ultimate completion date of October 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Veltassa is a potassium-binding medication used to treat hyperkalemia, a condition characterized by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count units) with a ceiling value of $1,358.10. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 15, 2025. Veltassa is a potassium-binding...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Veltassa 8.4 GM powder packets (30-count) valued at $3,964.51. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 19, 2025. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,173.79 to AmerisourceBergen Drug Corp for Veltassa 8.4 GM powder packets (30-count). The contract, issued on July 10, 2025, with an ultimate completion date of July 11, 2025, utilizes firm fixed-price pricing under a non-set-aside competitive procurement. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $14,202.32 to AmerisourceBergen Drug Corp for the supply of Veltassa 8.4 GM powder packets (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime...
- This delivery order, awarded May 12, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Veltassa 8.4 GM Powder Packet in a 30-count configuration with a ceiling value of $1,526.51. The contract represents a firm fixed-price delivery order with an ultimate completion date of May 13, 2025, and is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract...
- The Defense Logistics Agency awarded a $5,834.39 delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Veltassa 8.4 gm powder packets (30-count units). The contract represents a non-set-aside, competitively awarded firm fixed-price delivery order with an ultimate completion date of October 23, 2025. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child contract under...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB26FWVSPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veltassa 8.4 GM Powder Packet 30s on November 3, 2025, with a ceiling value of $1,984.07. This is a firm fixed price contract with an ultimate completion date of November 4, 2025. The award represents a non-competitive, non-set-aside delivery order placed under AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical supplier to federal medical procurement systems. Veltassa is a potassium-binding medication used in clinical settings to manage hyperkalemia. This delivery order is a child contract executing under AmerisourceBergen's larger $999.999 billion indefinite delivery contract with DLA Troop Support Medical through December 2026, which authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/3/25 |